Login
Subscribewarning letter
FDA Warns Liquid Biopsy Maker
Bob Grant | Sep 25, 2015 | 2 min read
The agency fires off a letter to Pathway Genomics, telling the company that its new cancer detection test could harm the public and is not validated by science.